CClinicalTrials.gg
Not yet recruitingNCT06426459Updated May 23, 2024

Social Media Usage in Adolescent Girls

An observational study in Menstrual Cycle and Oral Contraceptive, sponsored by International Research Training Group 2804. Not yet recruiting at 1 site in Germany. Open to female participants aged 15 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-23.

Sponsored by International Research Training Group 2804 · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
70
Ages
15 Years to 18 Years
Sex
Female
01

Study summary

The study aims to explore the effects of hormonal fluctuations throughout the menstrual cycle on social media use, brain architecture, neural reward processing and reward behavior, and affective status in adolescent girls. Additionally, it strives to compare the effects of exogenous and endogenous hormones on the above-mentioned aspects. For this purpose, the investigators will compare two main groups in the study: 1. Naturally cycling adolescent girls, 2. Adolescent girls using combined oral contraceptives. This study will combine self-report data via questionnaires, ecological data via Ecological Momentary Assessment (EMA), endocrine data via blood collection, and neural data via fMRI assessment to enhance the understanding of the neurobiological mechanisms underlying social media use in adolescent girls. Furthermore, it seeks to elucidate whether there are vulnerable periods throughout the menstrual cycle when adolescent girls are especially prone to dysfunctional social media use and help to design more specific interventions as well as therapy.

Read the detailed description

For each participant, there is a screening session, a month-long EMA assessment and two experimental fMRI sessions are planned.

After making sure the participants fill the inclusion and exclusion criteria, the investigators will invite them to the laboratory for a screening session (T0). In this session, the participants will provide written informed consent and assent in case of those under 18 years old and written, informed consent for those who are 18 year old. Furthermore, the participants will participate in a standardized clinical interview to screen for mental disorders (Kinder-DIPS). Subsequently, they will be informed about the study details. Finally, they will fill out questionnaires about personality, depressive symptoms, anxiety symptoms, gender identity and norms, mood, loneliness, social media disorder, internet use, social support, and fear of missing out.

Naturally cycling adolescent girls will join the two fMRI measurements (T1 \& T2) during the follicular and luteal phase of the menstrual cycle. Adolescent girls using combined oral contraceptives will join the first fMRI measurement during the pill intake period, and the second measurement during the break period. The fMRI sessions will comprise of filling out questionnaires, fMRI measurements, and blood collection for hormonal assessment.

Questionnaires on depressive symptoms, state anxiety, mood, gender identity, self-esteem, loneliness, fear of missing out (FOMO), social media disorder, internet use, social support and social media use will be administered through RedCap platform. This will ensure the assessment of subjective, self-report data and its changes throughout the measurement time of one month.

The sequence of fMRI measurements incudes four main parts, namely anatomical scan, resting-state scan, Effort Allocation Task (EAT), and diffusion tensor imaging (DTI). This protocol ensures the acquisition of the structural and functional data of the brain in the participants. The detailed protocol components are as follows:

  1. Anatomical scan: This first sequence of the protocol ensures assessment and insight into the anatomy of the brain, thus providing structural data of the participants' brain. This will last approximately 8 minutes.
  2. Resting-state scan: The next sequence involves participants watching a movie that was designed to improve imaging at rest for approximately 10 minutes. This sequence ensures insight into brain activity when no task is being performed and when the participant is at rest.
  3. Effort Allocation Task (EAT): This next sequence aims to assess reward processing and reward behavior in the participants. During this task, participants have to exert physical effort on a grip force device when faced with monetary points at stake. There are two types of reward a participant can face; low and high reward. Additionally, there are two difficulty levels during the task, one being easier and the other more difficult. The payoff for the invested effort will be proportional to its duration. The task will last approximately 17 minutes.
  4. Diffusion Tensor Imaging (DTI): During the final sequence, participants will undergo DTI assessment to ensure insight into white matter microstructure and connectivity. This will last approximately 7-8 minutes.

To thoroughly investigate the participants' experiences in their natural environments, Ecological Momentary Assessment (EMA) will be conducted. This will be done through an app called m-Path where participants will fill out daily questionnaires about social media use, self-esteem, premenstrual symptoms, and mood throughout one month. A daily questionnaire lasts approximately 10 minutes. This assessment will ensure data about subjective experiences with high ecological validity.

02

Conditions studied

  • Menstrual Cycle
  • Oral Contraceptive

Keywords

  • Social media use
  • Adolescent girls
  • Menstrual cycle
  • Oral contraceptive
  • Neuroimaging
  • Women's mental health
03

In context

Lead sponsor

International Research Training Group 2804 is the lead sponsor of 8 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study participants will be primarily recruited from residents of Tübingen and surrounding areas.

Inclusion criteria

  • Between 15 and 18 years old adolescent girls
  • Body mass index(18-25kg/m2)
  • Natural menstrual cycle (between 25 to 31 days) OR use of combined oral contraceptives for at least 4 months
  • Social media use (e.g., Instagram, TikTok, Snapchat, Facebook, X, BeReal)
  • Non-smoking
  • German language fluency
  • Attending age-appropriate school

Exclusion criteria

Exclusion Criteria:

  • Any neurological or psychiatric disease based on the standardized diagnostic interview (Kinder-DIPS)
  • Medical problems such as hormonal, metabolic, developmental or chronic diseases (e.g., congenital disorders, diabetes, dysfunctions of the thyroid, or congestive heart failure)
  • Pregnancy
  • Females who gave birth or were breastfeeding within the last year
  • Use of any other kind of steroid hormonal treatment (except combined oral contraceptives) or psychotropic treatment in the last three months
  • Females with premenstrual dysphoric disorder(PMDD)
  • Not willing to be informed about incidental fMRI findings

Additional exclusion criteria for fMRI:

  • Individuals with non-removable metal objects on or in the body such as cardiac pacemaker, artificial heart valve, metal prostheses, metal implants, metal splinters, etc.
  • Tattoos (if fMRI-incompatible according to expert guidelines)
  • Claustrophobia
  • Surgery less than three months ago
  • Pathological hearing or increased sensitivity to loud noises
  • Neurological disease or injury
  • Moderate or severe head injury
  • Restricted (corrected) vision
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
70 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Natural menstrual cycle

    Adolescent girls who have a natural menstrual cycle and have not used any kind of hormonal contraception for at least 6 months.

  • Oral contraceptive

    Adolescent girls who use combined oral contraceptives for at least 4 months.

06

What researchers measure

Primary outcomes

  1. Brain disparities: Contrasting naturally cycling adolescent girls with those using combined oral contraceptives

    Possible differences between naturally cycling adolescent girls and those taking combined oral contraceptives in brain structure

    Time frame: Measured twice appr. 2-3 weeks apart; approximately 45 minutes each time

  2. Brain disparities: Contrasting naturally cycling adolescent girls with those using combined oral contraceptives

    Possible differences between naturally cycling adolescent girls and those taking combined oral contraceptives in brain function (functional activation based on BOLD effect)

    Time frame: Measured twice appr. 2-3 weeks apart; approximately 45 minutes each time]

  3. Reward-processing disparities: Contrasting naturally cycling adolescent girls with those using combined oral contraceptives

    Possible differences between naturally cycling adolescent girls and those taking combined oral contraceptives on reward processing

    Time frame: Measured twice appr. 2-3 weeks apart; approx. 17 minutes each time

  4. Social media use disparities: Contrasting naturally cycling adolescent girls and those using combined oral contraceptives

    Possible differences in social media use between the two groups

    Time frame: Measured through ecological momentary assessment every day throughout one month

Secondary outcomes

  1. Social media use disparities: Contrasting follicular and luteal phase in naturally cycling adolescent girls

    Possible differences between the two phases of the menstrual cycle in social media use

    Time frame: Measured through ecological momentary assessment every day throughout one month

  2. Brain Disparities: Contrasting follicular and luteal phase in naturally cycling adolescent girls

    Possible differences in brain function and structure in naturally cycling girls in follicular vs. luteal phase

    Time frame: Measured twice appr. 2-3 weeks apart; circa 45 minutes each time

  3. Reward-processing disparities: Contrasting follicular and luteal phase in naturally cycling adolescent girls

    Possible differences in reward processing and reward behavior between the two menstrual cycle phases

    Time frame: Measured twice appr. 2-3 weeks apart; circa 45 minutes each time

  4. Associations between personality and brain function & structure

    Possible effects of personality type on brain structure and brain function for both groups. Personality measured by the NEO-Five-Factor-Inventory.

    Time frame: Measured twice appr. 2-3 weeks apart; circa 45 minutes each time

  5. Associations between personality and reward processing & behavior

    Possible effects of personality type on reward processing for both groups. Personality measured by the NEO-Five-Factor-Inventory.

    Time frame: Measured twice appr. 2-3 weeks apart; circa 17 minutes each time

  6. Self-esteem differences: Contrasting follicular and luteal phase in naturally cycling adolescent girls

    Possible differences in self-esteem between the two phases of the menstrual cycle

    Time frame: Measured through ecological momentary assessment every day throughout one month

07

Study locations

1 site
  • University Clinic Tuebingen, Department of Psychiatry & Psychotherapy
    Tuebingen, Baden-Wuerttemberg 72076, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06426459
Lead sponsor
International Research Training Group 2804
Collaborators
German Research Foundation, University Hospital Tuebingen, Uppsala University
Responsible party
Sponsor
First posted
May 23, 2024
Start date
May 29, 2024 (estimated)
Primary completion
Dec 1, 2025 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
May 23, 2024

Study contacts

Edita Karavidaj, MSc
Contact
edita.karavidaj@med.uni-tuebingen.de
+491746443856
Isabel Brandhorst, Dr. Dipl.-Psych.
Contact
isabel.brandhorst@med.uni-tuebingen.de
Tobias Renner, Prof. Dr. med.
principal investigator · Child Psychiatry, University Clinic Tübingen
Tomas Furmark, Dr.
principal investigator · Department of Psychology, Uppsala University, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion